Evaluation of entinostat alone and in combination with standard-of-care cytotoxic agents against rhabdomyosarcoma xenograft models.
Saved in:
| Title: | Evaluation of entinostat alone and in combination with standard-of-care cytotoxic agents against rhabdomyosarcoma xenograft models. |
|---|---|
| Authors: | Kurmasheva RT; Greehey Children's Cancer Research Institute, UT Health San Antonio, Texas., Bandyopadhyay A; Greehey Children's Cancer Research Institute, UT Health San Antonio, Texas., Favours E; Greehey Children's Cancer Research Institute, UT Health San Antonio, Texas., Del Pozo V; Greehey Children's Cancer Research Institute, UT Health San Antonio, Texas., Ghilu S; Greehey Children's Cancer Research Institute, UT Health San Antonio, Texas., Phelps DA; Greehey Children's Cancer Research Institute, UT Health San Antonio, Texas., Erickson SW; Research Triangle Institute, Research Triangle Park, North Carolina., Peer CJ; Clinical Pharmacology Program, NCI, Bethesda, Maryland., Figg WD; Clinical Pharmacology Program, NCI, Bethesda, Maryland., Smith MA; Cancer Therapy Evaluation Program, NCI, Bethesda, Maryland., Houghton PJ; Greehey Children's Cancer Research Institute, UT Health San Antonio, Texas. |
| Source: | Pediatric blood & cancer [Pediatr Blood Cancer] 2019 Aug; Vol. 66 (8), pp. e27820. Date of Electronic Publication: 2019 May 16. |
| Publication Type: | Evaluation Study; Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
